Trial no.:
|
PACTR201610001826216 |
Date of Approval:
|
17/10/2016 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Remote ischemic preconditioning and acute kidney injury |
Official scientific title |
Role of remote ischemic preconditioning on acute kidney injury reduction after hepatobiliary surgeries, a prospective randomized double blinded controlled study |
Brief summary describing the background
and objectives of the trial
|
Acute kidney injury (AKI) is a broad clinical syndrome ranging from mild alteration in kidney function biochemical markers level to overt kidney dysfunction. AKI is associated with increased morbidity and mortality including accelerated progression to end-stage renal disease and death .AKI is associated with increased cost and hospital stay .
Post-operative AKI is extensively studied in cardiac surgeries with limited studies in non-cardiac surgeries as major abdominal surgeries confirmed that AKI is common after major abdominal surgeries and associated with increased mortality Ischemic preconditioning refers to a mechanism in which a prior, short, ischemic period induces some protection against a subsequent prolonged ischemic and reperfusion damage. This can be done by remote organ ischemia (upper limb or lower limb) .
In this study we will assess if remote ischemic preconditioning will affect incidence of acute kidney injury after hepatobiliary surgeries.
¿
We hypothize that remote ischemic preconditioning will reduce the rate and the severity of acute kidney injury after hepatobiliary surgeries.
This study aims to assess the impact of remote ischemic preconditioning on rate and severity of acute kidney injury after hepatobiliary surgeries (primary variable), also will assess impact of remote ischemic preconditi |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
acute kidney injury,Kidney Disease,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Prevention |
Anticipated trial start date |
18/10/2016 |
Actual trial start date |
22/10/2016 |
Anticipated date of last follow up |
18/04/2017 |
Actual Last follow-up date |
22/04/2017 |
Anticipated target sample size (number of participants) |
120 |
Actual target sample size (number of participants) |
120 |
Recruitment status |
Recruiting |
Publication URL |
|
|